According to Genscript Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.66625. At the end of 2022 the company had a P/S ratio of 10.8.
Year | P/S ratio | Change |
---|---|---|
2022 | 10.8 | -43.18% |
2021 | 19.0 | 161.8% |
2020 | 7.25 | -53.6% |
2019 | 15.6 | 45.77% |
2018 | 10.7 | -62.87% |
2017 | 28.9 | 315.63% |
2016 | 6.94 | 120.88% |
2015 | 3.14 |